Read the analysis, not just the data.
Structured, AI-synthesised reports on every NSE-listed Indian stock — snapshot, strengths, weaknesses, peer ranking, risk flags, and the questions to ask yourself. Refreshed nightly. 500 stocks. Free. No signup.
See it in action · sample analysis· refreshed 4 days ago
Maruti Suzuki India Ltd.
Snapshot
Maruti Suzuki (₹13,395) is India's largest passenger vehicle maker by market share, trading above its 50-DMA (₹13,270) but 9.8% below the 200-DMA (₹14,854) and 22.88% off its 52-week high. Trailing PE of 28.7x compares to a forward PE of 21.7x, reflecting market expectations of earnings recovery. Over 5 years, revenue grew 28.2% while earnings declined 6.4%, and ROE of 14.43% sits below all profitable Auto sector peers.
Strengths
- +Debt-to-equity of 0.096 is near-zero, with a falling debt trend over the review period — balance sheet leverage is minimal relative to Auto sector norms.
- +FCF was positive in 4 of the 5 tracked years, and consistency score of 84 reflects above-average financial discipline across the measurement horizon.
Weaknesses
- −5-year earnings growth of -6.4% against revenue growth of 28.2% indicates that higher revenues have not translated to profit growth over the historical window.
- −ROE of 14.43% (2 of 5 years above 15%) is the weakest among profitable Auto peers, which range from M&M at 18.75% to Bajaj Auto at 28.05%.
How this is different
Read the analysis, not the tables
Most platforms surface raw fundamentals + technicals and leave the synthesis to you. Every stock here has a structured written report — snapshot, what's working, what isn't, peer ranking — refreshed nightly.
Fully free, no Pro paywall
Every stock, every section, every backtest — no signup gate, no "upgrade for filter X", no tiered downloads. The full NIFTY 500 is open to everyone.
Fresh data you can audit
Fundamentals refresh daily, AI synthesis every 5 days. Each stock page shows when each section was last updated — so you know if the analysis is from today or last week.
Descriptive, not advisory
No "Strong Buy" ratings, no price targets, no signal CTAs. We describe what the data shows; the decisions are yours.
Research Laboratory
Validate your hypothesis with deep historical data.
Backtest
Strategy Backtesting Engine
Simulate complex equity strategies across up to 20 years of NSE data. Account for slippage, brokerage costs, and position sizing with a single click. Equity curve, drawdowns, win rate, profit factor, and a full trade log on every run.
Equity Curve Simulation
+24.8% CAGR
Validate
Walk-Forward Analysis
Split history into rolling train/test windows. See how the strategy would have performed on out-of-sample data — without future-leak.
Diagnose
AI Insights & Risk Laboratory
Surfaced findings on overfitting risk, recovery time, losing-streak distribution, and benchmark alpha. Strictly descriptive — not advice.
Popular stocks
Click any stock to read today's analysis.
Investment Themes
Investment ideas structured around fundamental themes, curated for long-term compounding.
Consistent Compounders
STABLENSE stocks with steady earnings growth, stable market share, and durable returns on equity over multiple cycles.
High Return on Equity
GROWTHCapital-efficient businesses generating superior returns on shareholder equity — quality leaders across sectors.
In Drawdown Zone
VALUEQuality stocks trading 15–30% below their 52-week highs — possible entry zones for contrarian readers.
What's on every stock page
Six sections, all data-driven, all updated daily.
Fundamentals
P/E, ROE, margins, debt, growth rates with 5-year persistence and sector medians for context.
Technicals
50/200-DMA, RSI, 52-week range, drawdown from highs, algorithmic support and resistance levels.
News and sentiment
Last 30 days of headlines from major sources, classified positive / neutral / negative.
Peer comparison
Compare against 5 same-sector NSE peers on P/E, ROE, quality score, and recent performance.
Risk flags
Structural concerns called out — high D/E, FCF deterioration, sentiment divergence, governance flags.
Questions to ask yourself
Open-ended prompts the analysis suggests you consider — never answers, never recommendations.
Analysis, not action
VivaTrades is a free data and tools platform for Indian retail investors. We aggregate publicly-available data from NSE filings, market data feeds, and news sources into structured analysis. We are not a SEBI-registered Investment Adviser or Research Analyst — we do not recommend stocks, publish price targets, or customise advice for you. All data is for educational purposes only. Past performance, whether actual or simulated, is not a guarantee of future results. Investments in securities are subject to market risks; please read all disclosure documents before investing.
Frequently asked
Is this investment advice?
No. VivaTrades describes what the data shows for any given NSE stock — fundamentals, technicals, news, and peer comparison. We do not recommend buying, selling, or holding. Every page surfaces 'questions to ask yourself' that help you frame your own thinking, not answers.
Where does the data come from?
NSE filings for index constituents. Public market data feeds for fundamentals (P/E, ROE, growth, etc.) and historical prices. Public news APIs for headlines. Sentiment is classified by an automated NLP pipeline. The full multi-section analysis is composed by an automated pipeline that runs nightly.
How often is the analysis updated?
Two layers, two cadences. Fundamentals, technicals, news and analyst data refresh nightly at 01:00 IST — daily for all 500 NSE stocks. The AI-synthesised narrative (snapshot, strengths, weaknesses, peer ranking, risk flags) refreshes at 04:30 IST on a rolling priority queue — about 100 stocks per night, so the full universe cycles every ~5 days while NIFTY 50 names stay fresh daily. Live prices on every stock page are fetched on-demand.
Is there a paid plan?
No. The current platform is free with no signup required. We may introduce optional advanced features later, but the core stock-analysis pages will always remain free.
Why don't you show price targets or buy/sell recommendations?
Issuing price targets or buy/sell recommendations to the public requires registration with SEBI as a Research Analyst or Investment Adviser. We've chosen to operate as a tools-and-data platform instead, which doesn't require registration. This means you get pure data; the decision-making is yours.
What stocks are covered?
The full NIFTY 500 index — covering ~95% of NSE-listed market capitalisation. Stocks are tiered as NIFTY 50 / 100 / 200 / 500 based on index membership.
Can I backtest strategies on these stocks?
Yes. Click 'Backtest' on any stock page, or go to /backtest directly. Pick from preset strategies (SMA crossover, RSI mean-reversion, breakout, etc.), configure parameters, and see the historical equity curve. Up to 20 years of NSE data, no signup needed.
Start with any NSE stock
No signup, no cost. Just pick a stock and read the analysis.
Browse 500 stocks